Abbio XR, Inc.
- Biotech or pharma, therapeutic R&D
- Academic, tech transfer
Abbio XR is a biotechnology startup pioneering long-acting peptide therapeutics using a novel hydrogel-based delivery platform. Our proprietary technology enables self-depoting, extended-release formulations of peptide drugs—achieving quarterly dosing and a slow, steady, and continuous therapeutic release. Our lead programs include GLP-1 receptor agonists for obesity and type 2 diabetes, with platform potential across multiple peptide-driven indications. Spun out from the University of Notre Dame and led by a multidisciplinary team of scientists and entrepreneurs, Abbio XR is actively seeking strategic partnerships to advance co-development, licensing, and investment opportunities.
Address
South BendIndiana
United States
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}